Peng Hu

1.9k total citations
73 papers, 1.4k citations indexed

About

Peng Hu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Peng Hu has authored 73 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Peng Hu's work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (11 papers) and RNA Research and Splicing (8 papers). Peng Hu is often cited by papers focused on RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (11 papers) and RNA Research and Splicing (8 papers). Peng Hu collaborates with scholars based in China, United States and France. Peng Hu's co-authors include Jun Ren, Yugang Zhuang, Yuanzhuo Chen, Tong Meng, Penghui Yan, Huabin Yin, Runzhi Huang, Zongqiang Huang, Xi Chen and Ping Bie and has published in prestigious journals such as PLoS ONE, Cancer Cell and ACS Applied Materials & Interfaces.

In The Last Decade

Peng Hu

72 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Hu China 20 733 486 261 200 198 73 1.4k
Debra F. Higgins Ireland 16 1.1k 1.5× 771 1.6× 373 1.4× 243 1.2× 163 0.8× 18 2.3k
Lin Fan China 22 559 0.8× 392 0.8× 220 0.8× 371 1.9× 166 0.8× 70 1.3k
Kun Wu China 19 838 1.1× 515 1.1× 121 0.5× 186 0.9× 138 0.7× 59 1.3k
Xiaoli Sun China 20 521 0.7× 209 0.4× 225 0.9× 212 1.1× 406 2.1× 59 1.6k
Cristian Loretelli Italy 20 570 0.8× 413 0.8× 196 0.8× 190 0.9× 135 0.7× 65 1.4k
Chunyan Gu China 24 1.5k 2.0× 678 1.4× 276 1.1× 368 1.8× 133 0.7× 93 2.3k
Zhen Yao China 13 451 0.6× 263 0.5× 443 1.7× 94 0.5× 347 1.8× 45 1.2k
Dong Chen China 26 861 1.2× 251 0.5× 300 1.1× 478 2.4× 171 0.9× 84 1.8k

Countries citing papers authored by Peng Hu

Since Specialization
Citations

This map shows the geographic impact of Peng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Hu more than expected).

Fields of papers citing papers by Peng Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Hu. The network helps show where Peng Hu may publish in the future.

Co-authorship network of co-authors of Peng Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Hu. A scholar is included among the top collaborators of Peng Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Hu. Peng Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmed, Eman, et al.. (2025). Determination and Disposition of the Aromatase Inhibitor Exemestane in CYP3A-Deficient Mice. Molecules. 30(7). 1440–1440. 1 indexed citations
2.
Talebi, Zahra, Yan Jin, Alice A. Gibson, et al.. (2024). Darolutamide does not interfere with OATP‐mediated uptake of docetaxel. International Journal of Cancer. 155(2). 314–323. 3 indexed citations
3.
Huang, Runzhi, Zhiwei Zeng, Jie Zhang, et al.. (2022). The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma. Cancer Control. 29. 2895469602–2895469602. 3 indexed citations
4.
Hu, Peng, Shouzhi Fu, Shuyi Wang, et al.. (2022). Ablation of FUNDC1-dependent mitophagy renders myocardium resistant to paraquat-induced ferroptosis and contractile dysfunction. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(9). 166448–166448. 36 indexed citations
5.
Sun, Mingming, Wenjing Zhang, Yaguang Bi, et al.. (2021). NDP52 Protects Against Myocardial Infarction-Provoked Cardiac Anomalies Through Promoting Autophagosome–Lysosome Fusion via Recruiting TBK1 and RAB7. Antioxidants and Redox Signaling. 36(16-18). 1119–1135. 15 indexed citations
6.
Li, Dan, Ningning Wang, Jiayu Chen, et al.. (2021). High Expression of LINC01268 is Positively Associated with Hepatocellular Carcinoma Progression via Regulating MAP3K7. OncoTargets and Therapy. Volume 14. 1753–1769. 2 indexed citations
7.
Wang, Shuyi, Jun Tao, Huaguo Chen, et al.. (2021). Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy. Acta Pharmaceutica Sinica B. 11(11). 3508–3526. 36 indexed citations
8.
Huang, Runzhi, Jie Zhang, Dianwen Song, et al.. (2020). Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma. Bioscience Reports. 40(7). 14 indexed citations
9.
Cassel, Teresa, Kun‐Yu Teng, Peng Hu, et al.. (2020). Regulation of hepatic glutamine metabolism by miR-122. Molecular Metabolism. 34. 174–186. 43 indexed citations
10.
Liu, Yandong, Zhiqiang Zhuang, Jipeng Ma, et al.. (2020). Beclin1 Haploinsufficiency accentuates second-hand smoke exposure -induced myocardial Remodeling and contractile dysfunction through a STING-mediated mechanism. Journal of Molecular and Cellular Cardiology. 148. 78–88. 20 indexed citations
11.
Tan, Ying, Mingming Sun, Wenjing Zhang, et al.. (2020). Cardamonin protects against lipopolysaccharide-induced myocardial contractile dysfunction in mice through Nrf2-regulated mechanism. Acta Pharmacologica Sinica. 42(3). 404–413. 52 indexed citations
12.
Wani, Nissar Ahmad, Li Ding, Peng Hu, et al.. (2019). Ibrutinib Potentiates Antihepatocarcinogenic Efficacy of Sorafenib by Targeting EGFR in Tumor Cells and BTK in Immune Cells in the Stroma. Molecular Cancer Therapeutics. 19(2). 384–396. 27 indexed citations
13.
Pang, Jiaojiao, Peng Hu, Shuyi Wang, et al.. (2019). Mitochondrial ALDH2 protects against lipopolysaccharide-induced myocardial contractile dysfunction by suppression of ER stress and autophagy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(6). 1627–1641. 78 indexed citations
14.
Yan, Penghui, Runzhi Huang, Peng Hu, et al.. (2019). Nomograms for predicting the overall and cause-specific survival in patients with malignant peripheral nerve sheath tumor: a population-based study. Journal of Neuro-Oncology. 143(3). 495–503. 22 indexed citations
15.
Zheng, Zixuan, Guanghua Wang, Dianwen Song, et al.. (2019). The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Mesothelioma With Bone Metastasis. Frontiers in Bioengineering and Biotechnology. 7. 257–257. 22 indexed citations
16.
17.
Hu, Peng. (2015). Analysis of disease investigation and long-term deformation characteristics of common fill embankment of the Qinghai-Tibet Highway. Rock and Soil Mechanics. 13 indexed citations
18.
Sun, Yingying, Yugang Zhuang, Wei Zhao, et al.. (2015). Effects of Kallistatin on Oxidative Stress and Inflammation on Renal Ischemia-Reperfusion Injury in Mice. Current Vascular Pharmacology. 13(2). 265–273. 17 indexed citations
19.
Shi, Xiujuan, Xianzhen Chen, Peng Hu, et al.. (2015). Lentivirus-mediated silencing of spindle and kinetochore-associated protein 1 inhibits the proliferation and invasion of neuronal glioblastoma cells. Molecular Medicine Reports. 11(5). 3533–3538. 14 indexed citations
20.
Zhang, Chen, Yuanzhuo Chen, Mingsong Wang, et al.. (2014). PPM1D silencing by RNA interference inhibits the proliferation of lung cancer cells. World Journal of Surgical Oncology. 12(1). 258–258. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Debra F. Higgins Breakdown of academic impact, for papers by Lin Fan Breakdown of academic impact, for papers by Kun Wu Breakdown of academic impact, for papers by Xiaoli Sun Breakdown of academic impact, for papers by Cristian Loretelli Breakdown of academic impact, for papers by Chunyan Gu Breakdown of academic impact, for papers by Zhen Yao Breakdown of academic impact, for papers by Dong Chen
Rankless by CCL
2026